Market Research Logo

Aperion Biologics Corp - Product Pipeline Analysis, 2017 Update

Summary

Aperion Biologics Corp (Aperion Biologics) is a medical device company that develops and commercializes animal-based tissue technology. The company’s products include ligament reconstruction. Its Z-Process of humanizing and sterilizing tissue can be applicable to tissues from orthopedic ligaments, bone, and meniscus to valves and vessels to soft tissue grafts for augmentation and repair. Aperion Biologics’ Z-Lig is a porcine-derived ACL reconstruction alternative. The company offers regenerative medicine with a technology that provides a solution to the surgical need for human based grafts from alternative source of tissue. It serves surgeons and patients. Aperion Biologics is headquartered in San Antonio, Texas, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Aperion Biologics Corp
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


Aperion Biologics Corp Company Overview
Aperion Biologics Corp Company Snapshot
Aperion Biologics Corp Pipeline Products and Ongoing Clinical Trials Overview
Aperion Biologics Corp – Pipeline Analysis Overview
Aperion Biologics Corp - Key Facts
Aperion Biologics Corp - Major Products and Services
Aperion Biologics Corp Pipeline Products by Development Stage
Aperion Biologics Corp Pipeline Products Overview
Z-Fix
Z-Fix Product Overview
Z-Lig BT+
Z-Lig BT+ Product Overview
Z-Lig BTB
Z-Lig BTB Product Overview
Z-Lig ST
Z-Lig ST Product Overview
Z-Meniscus
Z-Meniscus Product Overview
Z-Patch
Z-Patch Product Overview
Aperion Biologics Corp - Key Competitors
Aperion Biologics Corp - Key Employees
Aperion Biologics Corp - Locations And Subsidiaries
Head Office
Recent Developments
Aperion Biologics Corp, Recent Developments
Apr 22, 2014: Aperion Biologics Granted CE Mark for Z-Lig ACL Replacement Device
Mar 11, 2014: France Dixon Helfer and Mike Ward Appointed to the Board of Directors of Aperion Biologics
Mar 28, 2012: Aperion Biologics Completes Enrollment In Z-Lig ACLR Medical Device Performance Trial
Sep 14, 2011: Aperion Biologics Reaches Midpoint Of Enrollment In Z-Lig Anterior Cruciate Ligament Reconstruction Medical Device Performance Trial
Feb 11, 2011: Aperion Biologics Initiates Clinical Trial Of Z-Lig Device For Anterior Cruciate Ligament Reconstruction
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report